Fibrosis is the formation of excess and abnormal fibrous connective tissue as a result of either a reparative or reactive process. A defining feature of connective tissue is its extracellular matrix, which provides structural support and also influences cellular activity. Two common human conditions that result from fibrosis are uterine fibroids (leiomyomas) and keloid scars. Because these conditions share a number of similarities and because their growth is due primarily to excessive extracellular matrix deposition, we compared the proteoglycans of uterine fibroids and keloid scars with corresponding normal tissues. Our analysis indicates that uterine fibroids and keloid scars contain higher amounts of glycosaminoglycans relative to normal myometrium and normal adult skin respectively. Proteoglycan composition is also different in the fibrotic tissues. Compared with unaffected tissues, uterine fibroids and keloid scars contain higher relative amounts of versican and lower relative amounts of decorin. There is also evidence for a higher level of versican catabolism in the fibrotic tissues compared with unaffected tissues. These qualitative and quantitative proteoglycan differences may play a role in the expansion of these fibroses and in their excessive matrix deposition and matrix disorganization, due to effects on cell proliferation, TGF (transforming growth factor)-β signalling and/or collagen fibril formation.
INTRODUCTION
It is now clear that the ECM (extracellular matrix) is not just a structural component of tissue, but that it also influences cell and organ function [1, 2] . The composition and architecture of the ECM can be altered in pathological situations, and these alterations can play a major role in disease aetiology and progression [3] . For example, normal ECM in a wound is degraded and replaced with altered granulation tissue matrix which facilitates healing [3, 4] . If the wound heals properly, this transitional matrix is removed and replaced with ECM that is typical for the normal tissue [3, 4] . In aberrant wound healing, such as scarring or fibrosis, the ECM consists of matrix molecules that fill the wound area, but do not provide proper functional integrity [4, 5] . As a result, tissue function is compromised.
Scarring typically occurs in tissues that have weak regenerative capacity, whereas fibrosis occurs when wounds, for reasons which are not clear, fail to progress to the ECM that is characteristic of the mature tissue and that was present before wounding. The ECM of fibrotic lesions has a disorganized architecture and an inappropriate composition of matrix molecules [3] [4] [5] . Importantly, the aberrant ECM of fibrotic lesions contributes to the continued presence of the fibrosis by influencing the function of the cells in the lesion [3, 4] .
Two pathological human conditions that are characterized by fibrosis are uterine leiomyomas (also known as uterine fibroids) and keloid scars of the skin. Uterine fibroids are benign solid tumours that arise from a clonal hyperproliferation of altered myometrial cells [6, 7] . Pathological and ultrasound examinations reveal that approximately 80 % of women in the U.S.A. harbour uterine fibroids [6, 8] . Keloid scars are benign fibroproliferative growths that occur at sites of cutaneous injury [3, 9] . Epidemiological evidence indicates that keloid scars occur in 5-15 % of wounds [3, 10] .
Uterine fibroids and keloid scars share a number of characteristics. Both conditions represent benign fibrous overgrowths that result primarily from excessive deposition of disorganized ECM as opposed to hyperproliferation of cells [3, 11] . There is evidence for a hereditary predisposition for both conditions [3, 9, 12, 13] , and both of these conditions are more prevalent in dark-skinned individuals [3, [8] [9] [10] [11] 14] . Uterine fibroids and keloid scars also share molecular similarities, such as increased TGF (transforming growth factor)-β levels and reduced dermatopontin levels [15] [16] [17] [18] . Owing to these similarities between uterine fibroids and keloid scars and because of their excessive ECM and its disorganized architecture, we compared the PGs (proteoglycans) of uterine fibroids and keloid scars with their corresponding unaffected tissues in order to assess whether PGs might play a common role in these fibrotic conditions.
EXPERIMENTAL

Materials
The sources of reagents and other supplies are as reported previously [19, 20] . Human tissue samples were obtained in accordance with the policies established by the Institutional Review Board of Case Western Reserve University and were obtained through the Tissue Procurement Core Facility, Cancer Center, Case Western Reserve University, Cleveland, OH, U.S.A. All procedures approved by our Institutional Animal Care and Use Committee are done in accordance with the Declaration of Helsinki (2000). All tissue samples were classified as discarded tissue from surgeries.
A total of four samples of uterine tissue were obtained from individuals of 41, 47, 48 and 49 years of age, of which the three youngest are Afro-American and the other is Caucasian. Samples of both uterine fibroid tissue and normal myometrium were Abbreviations used: ECM, extracellular matrix; EGF, epidermal growth factor; GAG, glycosaminoglycan; PG, proteoglycan; TGF, transforming growth factor. 1 To whom correspondence should be addressed (email dac5@case.edu).
obtained from the same individuals. All of the uterine fibroids were intramural. From the donor of 47 years of age, two samples of fibroid tissue were obtained, one from a large fibroid (larger than 2 cm) and one from a small fibroid. From the other three donors, only small fibroids were obtained. A total of four samples of keloid scar tissue were obtained from individuals of 15, 16, 17 and 22 years of age. All samples are from Afro-Americans and are from the pinna; all are from females, except the sample from the individual of 17 years of age. Because no unaffected tissue could be obtained from the same individuals, three samples of normal adult skin from other donors were used for comparison. These samples are from individuals of 19, 23 and 35 years of age, and all are breast skin from AfroAmerican females.
PG extraction, isolation and analysis
PGs were extracted from minced tissues and isolated by anionexchange chromatography on DEAE-Sephacel as described previously [19] . The anion-exchange columns were eluted in a stepwise fashion with 0.25 M and then 1.0 M NaCl [19] . The lower salt eluate is designated DEAE pool 1 and contains hyaluronan and some loosely bound glycoproteins, whereas the higher salt eluate is designated DEAE pool 2 and contains the sulfated PGs [19] . The amount of GAG (glycosaminoglycan) in each of the pools was determined with a Safranin O assay [20] .
Gel electrophoresis and immunoblotting
Electrophoresis on polyacrylamide gels, electrotransfer on to Immobilon-P and immunoblotting were performed as described previously [19] . Samples were analysed as intact PGs or as core proteins after treatment with chondroitinase ABC. Analysis of versican was performed on composite gels of agarose and polyacrylamide as reported previously [19] , except that the composite gels were run as mini-gels [21] . Samples on each gel were loaded at equal amounts on the basis of the amount of GAG determined by Safranin O assay of the DEAE pools. Gels were either stained with Toluidine Blue or transferred for immunoblots. Densitometry was performed with GelQuant.NET software (provided by http://biochemlabsolutions.com/) and with ImageJ [22] .
A total of three antibodies/antisera were used to analyse versican on immunoblots: 12C5, 2B1 and anti-DPEAAE. The specificities of these have been described in detail elsewhere [23] . Briefly, the monoclonal antibody 12C5 recognizes an epitope in the G1 domain of human versican [24] , and the monoclonal antibody 2B1 recognizes an epitope in the G3 domain of human versican (K. Kimata, personal communication). The neoepitope anti-DPEAAE antiserum recognizes the amino acid sequence DPEAAE only when this epitope occurs at the C-terminus of the core protein. As such, the anti-DPEAAE antibody recognizes catabolic fragments of the V0 and V1 splice variants of versican that have been cleaved at this site [23, 25] . Decorin and biglycan were analysed with 6B6 and LF-121 respectively. The former is a monoclonal antibody that recognizes an epitope near the Nterminus of human decorin [26] . LF-121 is a polyclonal antiserum that recognizes the core protein of human biglycan [27] . A major catabolic fragment of decorin that is detected in adult human skin was analysed with the neoepitope anti-VRKVTF antiserum [20] .
RESULTS
PG quantification
Total GAG content in each of the tissue samples was measured as the sum of the GAGs eluted from DEAE-Sephacel in pools The quantitative results show that both uterine fibroids and keloid scars contain higher levels of GAGs relative to the corresponding normal tissues (normal myometrium and normal adult skin respectively). As a function of wet weight of starting tissue, the affected tissues contain 2-3-fold higher amounts of GAGs than the normal tissues (Tables 1 and 2 ). For uterine fibroids, this comparison was made for normal and affected tissues obtained from the same uterus. Although there is some variability in the values for normal myometrium, in every sample set the value for fibroid tissue is higher than that for normal myometrium ( Table 1) . As unaffected tissue could not be obtained from keloid scar donors, these comparisons were made with samples of normal adult skin obtained from donors as close as possible in age to the keloid scar donors. Initial analysis of the PG samples (i.e. DEAE pool 2) by SDS/PAGE and Toluidine Blue staining showed that all of the samples contain three major bands. Out of these bands, two migrate well into the gels and, as discussed below, were identified as decorin and biglycan. The third band barely migrates into the gels and is presumed to contain versican, because this band is not detected in samples that are treated with chondroitinase ABC prior to electrophoresis (results not shown). Versican is a very large molecule and, as such, migrates very little into polyacrylamide gels and also does not transfer efficiently out of polyacrylamide gels for immunoblots [19] .
PG analysis: versican
As SDS/PAGE is not suitable for versican analysis, this PG was analysed with composite gels. Owing to the large pore size 
Figure 2 Composite gels of PGs from uterine and skin samples
Aliquots of DEAE pool 2 prepared from uterine fibroids and normal myometrium (left-hand panel) or keloid scars and normal adult skin (right-hand panel) were electrophoresed on composite gels of agarose and polyacrylamide, and the gels were stained with Toluidine Blue. The samples are as indicated. The circle in each of the images is from the container in which the gels were photographed.
of these gels, versican migrates well into composite gels and transfers efficiently from these gels for immunoblots. Relative versican levels were assessed on immunoblots of composite gels probed with 12C5. These immunoblots show that the versican band is more intense in PG samples from uterine fibroids and keloid scars compared with the corresponding unaffected tissues ( Figure 1A ). This was confirmed by densitometry ( Figure 1B) . On composite gels stained with Toluidine Blue, the bands of large PGs (which contain versican) are more intense for the affected tissues compared with the corresponding unaffected tissues (Figure 2 ). This difference is more pronounced for the skin samples, but is also observed for the uterine samples. The differences in versican abundance between normal and affected tissues (Figures 1 and  2 ) are more pronounced for the skin samples owing to the fact that the versican bands are less intense in samples of normal adult skin than in samples of normal myometrium ( Figure 1B) . As an equal amount of GAGs was loaded for all samples, for both the immunoblots and the Toluidine Blue-stained composite gels, the greater intensity of the versican bands in the affected tissues indicates that these tissues contain higher relative amounts of versican than the corresponding unaffected tissues.
Both uterine fibroids and keloid scars contain higher relative amounts of versican catabolic fragments than the corresponding normal tissues. This is evident from 12C5 and anti-DPEAAE immunoblots of samples resolved by SDS/PAGE. Intact versican (i.e. versican containing its GAGs) cannot be detected on these immunoblots because it is too large to transfer out of polyacrylamide gels. However, the core proteins of versican can be analysed on SDS/PAGE immunoblots for samples that are treated with chondroitinase ABC before electrophoresis [19, 23] . Comparison of undigested (i.e. intact) and chondroitinase ABCdigested aliquots of two of the uterine fibroid samples confirms this, in that bands are detected only in the digested aliquots ( Figure 3A , left-hand panel). Similar results were obtained for all of the other samples (results not shown).
It has been shown previously that there are four major versican core proteins present in normal human skin [23] . Three of these (designated bands 1 to 3) are recovered in DEAE pool 2. Band 1 was identified as the V0 splice variant of versican and band 2 as the V1 splice variant. Band 3 was identified as a catabolic fragment of V0 with DPEAAE as its C-terminus. Proteins that migrate similarly to bands 1, 2 and 3 are detected on 12C5 immunoblots of all samples from both affected and unaffected tissues ( Figures 3  and 4 , left-hand panels). As with normal human skin [23] , only band 3 is recognized by the anti-DPEAAE antibody ( Figures 3  and 4 , right-hand panels). This indicates that band 3, but not bands 1 and 2, is a catabolic fragment of versican with DPEAAE as its C-terminus. The intensity of band 3 is generally higher in samples from affected tissues compared with unaffected tissue, which is more apparent on the 12C5 immunoblots ( Figures 3  and 4 , left-hand panels). This is observed for both uterine fibroid and keloid scar (with the possible exception of the keloid scar sample from the 17-year-old individual). Additional bands migrating between bands 2 and 3 are detected on the 12C5 immunoblots of uterine samples (Figure 3 , left-hand panels). These bands are not recognized by the anti-DPEAAE antibody (Figure 3 , right-hand panels) and may represent catabolic fragments which do not have DPEAAE as their C-termini.
The fourth major versican core protein of normal human skin (band 4) was identified as a catabolic fragment of V1 with DPEAAE as its C-terminus [23] . Owing to the location of the DPEAAE cleavage site, band 4 lacks the GAGs of V1. Consequently, band 4 elutes in DEAE pool 1 and does not require prior digestion with chondroitinase ABC for detection on SDS/PAGE immunoblots. Analysis of DEAE pool 1 shows the presence of band 4 on both 12C5 and anti-DPEAAE immunoblots ( Figures 5 and 6 ). Similar to band 3, band 4 is in general more intense in the samples from affected tissues (with the possible exception of the keloid scar samples fron the 16-and 17-year-old individuals). On composite gel immunoblots of DEAE pool 2 probed with anti-DPEAAE antibody, the bands are more intense for the samples from affected tissues compared with unaffected tissues (results not shown), which correlates with the anti-DPEAAE SDS/PAGE immunoblots and provides further evidence that versican catabolic fragments are more abundant in the affected tissues. The higher relative amounts of versican catabolic fragments in the majority of the samples of affected tissues suggest that there is increased versican catabolism in the fibrotic tissues.
PG analysis: small PGs
Analysis of the PGs by SDS/PAGE and Toluidine Blue staining indicates that decorin and biglycan are present in all of the samples ( Figure 7A ). The identities of the bands labelled as decorin and biglycan were confirmed on immunoblots probed with appropriate antibodies (results not shown). Some of the
Figure 4 SDS/PAGE immunoblot analysis of versican core proteins from skin samples
Aliquots of DEAE pool 2 prepared from keloid scars and normal adult skin were treated with chondroitinase ABC and electrophoresed on 5 % polyacrylamide gels. The gels were used for immunoblots that were probed with 12C5 for versican core proteins (left-hand panel) or with anti-DPEAAE antibody for the versican catabolic fragments that terminate at DPEAAE (right-hand panel). The samples are as indicated. The core protein bands previously identified in human skin are indicated as bands 1, 2 and 3. Molecular masses in kDa are indicated to the left-hand side.
Figure 5 SDS/PAGE immunoblot analysis of versican core proteins from uterine samples
Aliquots of DEAE pool 1 prepared from uterine fibroids and normal myometrium were electrophoresed on 5-17.5 % polyacrylamide gels without prior treatment with chondroitinase ABC. The gels were used for immunoblots that were probed with 12C5 for versican core proteins (left-hand panel) or with anti-DPEAAE antibody for the versican catabolic fragments that terminate at DPEAAE (right-hand panel). The samples are as indicated. The core protein band identified previously in human skin is indicated as band 4. Molecular masses in kDa are indicated on the left-hand side.
biglycan identified on immunoblots migrates similarly to decorin (results not shown). This has been reported previously for human skin [19] , and this biglycan has been interpreted to be biglycan containing only a single GAG chain [28] . On LF-121 SDS/PAGE immunoblots of all of the samples, from both affected and unaffected tissues, the band of monoglycanated biglycan is much less intense than the band of fully glycanated biglycan (results not shown). Immunoblot analysis with anti-VRKVTF, a neoepitope antiserum that recognizes a catabolic fragment of decorin present in normal adult human skin [20] , did not detect this fragment in all uterine and keloid scar samples (results not shown). This catabolic fragment is observed as a diffuse Toluidine Blue-stained band migrating at approximately 45 kDa in normal adult skin, but not in the keloid scar samples or in any of the uterine samples ( Figure 7A ). These results suggest that, in contrast with versican, decorin catabolism is not increased in the fibrotic tissues.
Toluidine Blue-stained gels show that the intensity of the decorin bands relative to the intensity of the biglycan bands is consistently stronger for samples of unaffected tissues compared with affected tissues ( Figure 7A) . Quantification of the band intensities confirms this observation ( Figure 7B ). These results provide evidence that the ratio of decorin to biglycan is lower for both uterine fibroids and keloid scars relative to normal tissues. Decorin and biglycan from the affected tissues migrate more slowly on SDS/PAGE than the corresponding PGs from unaffected tissues ( Figure 7A ). This observation is more pronounced for the keloid scar than for the uterine fibroid. Immunoblot analysis of aliquots treated with chondroitinase ABC before electrophoresis shows that the core protein bands for decorin migrate similarly for affected and unaffected tissues (results not shown), and this is also observed for the biglycan core protein bands (results not shown). The core protein bands exhibit patterns that are similar to those reported previously for these PGs in samples of human skin [19, 23] . Taken together, the slower migration for the small PGs of affected tissues and the similar migration for their core proteins is evidence that decorin and biglycan of the uterine fibroid and keloid scar have larger GAGs compared with these PGs in the corresponding normal tissues.
Decorin and biglycan were analysed further on composite gel immunoblots. These gels were used for quantitative comparisons because, as with versican, the large pore size of these gels facilitates efficient transfer of the small PGs. For both uterine fibroids and keloid scars, the decorin bands are less intense for the samples from affected tissues compared with samples from unaffected tissues ( Figure 8A ), an observation that was confirmed by densitometry ( Figure 8B ). Although this difference is observed for both uterine tissue and skin, it is more pronounced for the skin samples. This is because the decorin bands are more intense in the samples of normal adult skin than for normal myometrium ( Figure 8B ). No clear difference is observed in the intensities of the biglycan bands for the affected and unaffected tissues ( Figure 9A ), and densitometry confirms this ( Figure 9B ). As equal amounts of GAG were loaded for all samples, the difference in the intensities of the decorin bands for the affected and unaffected tissues suggests that there is a decreased relative amount of decorin in uterine fibroids and keloid scars.
DISCUSSION
Our analysis in the present study indicates that there are differences in the PGs of uterine fibroids and keloid scars relative (A) Aliquots of DEAE pool 2 prepared from uterine fibroids and normal myometrium (left-hand panel) or keloid scars and normal adult skin (right-hand panel) were electrophoresed on 5-17.5 % gradient polyacrylamide gels, and the gels were stained with Toluidine Blue. The samples are as indicated. For this analysis, the sample of normal adult skin is from an individual of 31 years of age; this sample gives results that are the same as those for the other samples of normal adult skin used in the present study. The sample of normal skin was loaded at two amounts: 5 μg, which is the same loading amount as the keloid scar samples, and 3 μg, which gives a band intensity for decorin that is comparable with that of the keloid scar samples to better facilitate comparison of the relative intensities of the decorin and biglycan bands. The images shown are representative of gels that were run at least twice with similar results each time. Molecular masses in kDa are indicated on the left-hand side. (B) The Toluidine Blue-stained gels shown in (A) were analysed by densitometry, and the intensities of the decorin and biglycan bands were used to calculate the ratio of decorin to biglycan. The samples are from the indicated donors (FL, large fibroid; FS, small fibroid; K, keloid scar; M, normal myometrium; N, normal skin). The results shown for normal adult skin are for the sample that was used in (A); these data are comparable with results for other samples of normal adult skin ( [19] and results not shown). to their corresponding normal tissue counterparts. In addition, uterine fibroids and keloid scars show similarities to each other in the way that their PGs differ from their unaffected tissues. Specifically, both of the affected tissues show higher amounts of GAG compared with the unaffected tissues. The fibrotic tissues also have higher relative amounts of versican and lower relative amounts of decorin than their corresponding unaffected tissues. These differences are observed at the protein level, which reflects the composition of the ECMs themselves. We also obtained evidence of a higher level of versican catabolism in the affected tissues compared with the unaffected tissues. The differences in the relative amounts of versican and decorin between the affected and unaffected tissues are more pronounced for the skin samples than the uterine samples. This is not so much because of differences in the relative levels of versican and decorin in keloid scars and uterine fibroids, but more so because of differences between normal adult skin and normal myometrium, in that the former has higher relative amounts of decorin and lower relative amounts of versican.
On composite gel immunoblots probed with monoclonal antibody 2B1, there are no clear differences in the intensities of the versican bands between affected and unaffected tissues (results not shown). This is in contrast with immunoblots probed with 12C5, on which the versican bands of the affected samples are more intense (Figure 1 ). Owing to the location of the 2B1 epitope (i.e. in the G3 domain of versican), this antibody recognizes full-length versican core protein, but not the catabolic fragments of versican that terminate at DPEAAE [23] . However, 12C5 recognizes both full-length versican core protein and the DPEAAE fragments [23] . The difference in the results for the 12C5 and 2B1 composite gel immunoblots suggests that most, if not all, of the difference in the relative amounts of versican between affected and unaffected tissues is due to higher relative levels of versican catabolic fragments in the former.
Our results from the present study showing similarity in the PG patterns of uterine fibroids and keloid scars correlate with studies showing other similarities between these two types of fibrotic tissues [3, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Also, our findings regarding the PGs of these fibrotic tissues correlate with some other studies. For example, lower SDS/PAGE mobility has been reported for decorin from uterine fibroids compared with normal myometrium [29] , although, to our knowledge, this comparison has not been performed for biglycan, nor has this comparison been performed for decorin and biglycan from keloid scar and normal skin. Lower decorin mRNA was found in uterine fibroids compared with normal myometrium [30] , and reduced decorin and decorin mRNA were found in keloid scar and fibroblasts from keloid scar respectively [31, 32] . Decreased levels of decorin and of decorin mRNA were also reported in hypertrophic scar, a condition that is similar to but less severe than keloid scar [33] . These authors also found increased biglycan and biglycan mRNA in hypertrophic scar [33] , which differs from our results in the present study for keloid scar, for which no clear differences were detected in biglycan at the protein level between the fibrotic tissue and normal skin ( Figure 9 ).
Our observation of an increase in the relative amount of versican protein in keloid scars and uterine fibroids correlates with a reported increase in versican mRNA in these tissues [17, 18] . An increase in versican was also reported at the protein level, but in that study versican was analysed on immunoblots probed only with anti-DPEAAE antibody [34] . Thus the analysis was, in fact, directed at versican catabolic fragments, and the increased anti-DPEAAE-reactive material observed by Norian et al. [34] for uterine fibroids matches the results from the present study, although this result was interpreted as an increase in versican. As no mention was made of the samples being treated with chondroitinase ABC prior to electrophoresis, the anti-DPEAAEreactive band identified by Norian et al. [34] is most likely to be the band that we refer to as band 4 (i.e. the DPEAAE fragment of versican V1), but the molecular mass of this band was not indicated [34] . Catherino et al. [18] also reported no difference in the level of decorin between the fibrotic tissues (uterine fibroid and keloid scar) relative to their corresponding unaffected tissues, although this was based on immunohistochemistry of tissue sections and the staining intensity was not quantified by image analysis. Owing to potential problems with quantification based on immunohistochemistry, for example due to antibody accessibility to molecules in tissue sections, our results with isolated PGs, which were obtained by densitometric quantification of immunoblots, are likely to be a more reliable comparison of the relative amounts of these molecules at the protein level in affected and unaffected tissues.
The PG differences between the affected and unaffected tissues may contribute to fibrosis. For example, higher levels of versican have been shown to result from genetic deletion of the enzyme that catabolizes this PG, and this correlates with a myofibroblast phenotype and with enhanced TGF-β signalling that is of a type that is consistent with fibrosis [35, 36] . The higher relative amounts of versican that we find in the fibrotic tissues are consistent with the biological effects that are observed in the genetic deletion studies. Our results from the present study also show that both versican levels and versican catabolism are higher in the fibrotic tissues. This suggests that the important factor is the increased amount of versican and not the reduced versican catabolism. Of note, versican catabolic fragments have been shown to elicit biological effects [37] .
There is evidence that fibrosis results from excessive signalling by TGF-β, which leads to excessive deposition of the ECM [38, 39] . Higher TGF-β levels have been found in uterine fibroids and keloid scars [15] [16] [17] , and decorin has been shown to antagonize TGF-β signalling [38] . As such, the lower relative levels of decorin in uterine fibroids and keloid scars may result in increased TGF-β signalling and therefore contribute to the fibrosis pathobiology. In this regard, decorin treatment of several in vivo models of fibrosis has been shown to ameliorate the fibrotic condition [40] [41] [42] [43] .
Decorin can also affect cell proliferation via the EGF (epidermal growth factor) receptor [44, 45] , and decorin treatment of in vivo neoplastic tumour models leads to a reduction in tumour growth, an effect that is mediated through decorin's interaction with the EGF receptor [46, 47] . As decorin is important in regulating the collagen architecture of the ECM [48] , the reduced amout of decorin in fibrotic tissues may lead to the aberrant collagen architecture that has been observed in uterine fibroids and keloid scars [49] . Biglycan has been reported to be associated with the thick collagen fibrils of mouse decidua [50] . A decrease in the ratio of decorin to biglycan, as we observe in the fibrotic samples, may result in an alteration in the proportions of these PGs that are associated with collagen fibrils and a concomitant alteration in the collagen architecture. Thus the PG differences that we find between fibrotic and normal tissues can play a role in ECM deposition, cell proliferation and/or collagen architecture in the affected tissues. This suggests that the fibrotic ECM may be involved in the pathophysiology of fibrosis.
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